The Efficacy of Probe-based Confocal Laser Endomicroscopy in Staging OLGIM

NCT02932735 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-10-13

No results posted yet for this study

Summary

Gastric intestinal metaplasia (GIM) is an important premalignant lesion for gastric cancer. Precisely surveillance of patients with GIM may result in early detection and improved prognosis. Though important, it is not necessary to recommend surveillance endoscopy for all patients with GIM, since the progression rate to gastric cancer within 10 years is only 1.8% in those patients.

Conditions

  • Probe-based Confocal Laser Endomicroscopy
  • the Operative Link on Gastric Intestinal Metaplasia

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • Li Yanqing, MD, PhD · Qilu Hospital of Shandong University

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-06-30
Completion
2017-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02932735 on ClinicalTrials.gov